BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.70
+0.05 (0.16%)
Apr 2, 2025, 1:30 PM CST

BioGend Therapeutics Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Revenue
167.65109.9131.459.271.39
Upgrade
Revenue Growth (YoY)
52.53%249.51%239.26%565.40%-4.65%
Upgrade
Cost of Revenue
37.1420.298.676.210.66
Upgrade
Gross Profit
130.5189.6222.783.060.73
Upgrade
Selling, General & Admin
124.0495.1675.7354.0940.14
Upgrade
Research & Development
128.72171166.27113.2794.21
Upgrade
Operating Expenses
252.77266.16241.99167.37134.35
Upgrade
Operating Income
-122.26-176.54-219.21-164.31-133.62
Upgrade
Interest Expense
-0.22-0.26-0.09-0.02-0.01
Upgrade
Interest & Investment Income
6.076.924.592.882.35
Upgrade
Earnings From Equity Investments
-2.46-0.84--11.35-14.24
Upgrade
Currency Exchange Gain (Loss)
-00.030.070.510.13
Upgrade
Other Non Operating Income (Expenses)
0.621.460.740.870.27
Upgrade
EBT Excluding Unusual Items
-118.25-169.22-213.9-171.4-145.12
Upgrade
Gain (Loss) on Sale of Investments
-10--26.7-
Upgrade
Gain (Loss) on Sale of Assets
-----0.48
Upgrade
Other Unusual Items
---0.44-
Upgrade
Pretax Income
-128.25-169.22-213.9-144.27-145.59
Upgrade
Income Tax Expense
-8.31-8.3-8.4--
Upgrade
Earnings From Continuing Operations
-119.94-160.92-205.5-144.27-145.59
Upgrade
Minority Interest in Earnings
3.474.5921.045.78-
Upgrade
Net Income
-116.47-156.33-184.46-138.49-145.59
Upgrade
Net Income to Common
-116.47-156.33-184.46-138.49-145.59
Upgrade
Shares Outstanding (Basic)
12312010310187
Upgrade
Shares Outstanding (Diluted)
12312010310187
Upgrade
Shares Change (YoY)
2.32%16.69%1.77%15.90%7.56%
Upgrade
EPS (Basic)
-0.95-1.30-1.79-1.37-1.67
Upgrade
EPS (Diluted)
-0.95-1.30-1.79-1.37-1.67
Upgrade
Free Cash Flow
-99.56-164.76-186.96-137.47-117.33
Upgrade
Free Cash Flow Per Share
-0.81-1.37-1.81-1.36-1.34
Upgrade
Gross Margin
77.85%81.54%72.44%33.00%52.48%
Upgrade
Operating Margin
-72.93%-160.63%-697.11%-1772.67%-9591.89%
Upgrade
Profit Margin
-69.47%-142.23%-586.58%-1494.07%-10451.83%
Upgrade
Free Cash Flow Margin
-59.38%-149.91%-594.54%-1483.13%-8422.90%
Upgrade
EBITDA
-74.76-125.21-170.87-137.9-114.42
Upgrade
EBITDA Margin
-44.59%-113.92%---
Upgrade
D&A For EBITDA
47.551.3348.3526.4119.19
Upgrade
EBIT
-122.26-176.54-219.21-164.31-133.62
Upgrade
EBIT Margin
-72.93%-160.63%---
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.